Talking Medtech Innovation and Commercialization Strategies at AdvaMed 2017

The MedTech Conference, AdvaMed’s flagship event, is the leading medtech industry conference in North America. September 25 – 27 in San Jose will find thousands of medtech industry leaders gathered together in a multifaceted environment for business development, capital formation, technology showcasing, world-class educational opportunities and networking at AdvaMed 2017. Tiffany Wilson, CEO of GCMI…

Fostering Medical Innovation in the Clinical Setting: Piedmont Innovations & GCMI

Who better to address unmet clinical needs and life-changing improvements to medical devices of all types than clinicians themselves? Piedmont Healthcare and T3 Labs’ a subsidiary of  GCMI, embark on a journey to create a self-sustaining innovation enterprise: concept to commercialization. All I.J. was trying to do was celebrate a friend’s wedding at the beach.…

Talking Good Lab Practices(GLP) with FDA Representatives and Industry Leaders at SQA 2017

The Society of Quality Assurance is dedicated to promoting quality in the regulated research community, including clinical settings, laboratories, and manufacturing facilities. This year the annual meeting, held March 26-31, boasted attendance of over 800. Located in National Harbor, Maryland, the conference was in close proximity to Washington DC, posing a unique opportunity for more…

Infection prevention in orthopedic medical devices, rigorous FDA regulations, & more: our AAOS 2017 takeaways

The American Academy of Orthopaedic Surgeons’ Annual Meeting (AAOS) is the premier ortho event of the year: hosting thousands of surgeons, medical device companies, thought leaders, and academics seeking the latest advancements and learnings in orthopaedic surgery. Leaders gathered together in San Diego from March 14th to the 18th. The new T3 Labs booth (a…

The importance of innovators working with third party design firms to get novel medical technologies to market

GCMI and T3 Labs CEO Tiffany Wilson shares insights with Assembly Magazine on what it takes to bring a medical device from concept to commercialization. Developing a new medical technology is not for the faint of heart. It is a daunting, expensive, arduous process, but nevertheless, it is highly rewarding. The developmental pathway is enough…